KRISTEN CLANCY: Open Payments
NPI 1942443668 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,047 in 110 payments from 20 companies in 2025. Trend: 2023 $2,020 · 2024 $2,020 · 2025 $2,047
Food & beverage: $2,047
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 27 | $243 |
| CVRx, Inc. | 8 | $229 |
| Edwards Lifesciences Corporation | 3 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $151 |
| Novartis Pharmaceuticals Corporation | 7 | $149 |
| PFIZER INC. | 9 | $144 |
| Alnylam Pharmaceuticals Inc. | 7 | $135 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 6 | $97 |
| Novo Nordisk Inc | 5 | $89 |
Products named: REPATHA, Barostim Neo System, JARDIANCE, LEQVIO, ONPATTRO, LifeVest, ELIQUIS, WATCHMAN FLX.
Industry payments across NY — which companies pay providers there.
